News & events.

TriSalus Life Sciences® Receives Expanded Reimbursement Authorization from CMS for TriNav® Infusion System

View now

TriSalus Life Sciences® Launches the New TriNav® Infusion System, an Innovative Solution Designed to Overcome Infusion Barriers Within Solid Tumors

View now

TriSalus Life Sciences®’ Surefire® Spark Infusion System (TriNav®) Receives CMS Approval for Transitional Pass-Through Payment Status

View Now

Let us tell you more.

Contact us to learn more about this improved technology for the proprietary PEDD approach.